Stocks of drug distributors and manufacturers fell after a Washington Post report on Tuesday evening identified a handful of companies as dominant sellers of opioids across the U.S. The hit to share prices suggests that investors haven’t fully priced in the fallout of the continuing opioid crisis.
Trending:
Drugmakers' stocks, distributors fall on opioid report. More losses could follow.